Literature DB >> 8647056

Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids.

A N Prasad1, C F Stafstrom, G L Holmes.   

Abstract

Despite the continued development and release of new antiepileptic drugs (AEDs), many children have seizures that do not respond to conventional therapy or have related side effects that preclude continued use. While some of these children are surgical candidates, the majority do not qualify for surgical resection. In these children alternative therapies are often considered by desperate physicians and parents. Three of the less conventional therapies which are currently used for intractable epilepsy are: the ketogenic diet, immunoglobulins, and steroids. None of these therapies has been adequately studied and it remains unclear which patients may benefit or be harmed by these therapies. Despite the lack of scientific vigor in evaluating these therapies, the television and print media has proclaimed these therapies as miraculous, yet grossly under-utilized by an ignorant medical community. The ketogenic diet has been demonstrated to reduce seizure frequency in some patients, but has an unclear mechanism of action, while immunoglobulins have both unknown efficacy and an unknown mechanism of action. While steroids are accepted as an effective therapy for infantile spasms, their role in the treatment of the Landau-Kleffner syndrome is far less clear. Although the ketogenic diet, immunoglobulins, and steroids may have a role in the treatment of severe childhood epilepsy, all three therapies need to be critically evaluated in regard to efficacy, mechanism of action, and safety.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647056     DOI: 10.1111/j.1528-1157.1996.tb06026.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders.

Authors:  R Tuchman
Journal:  J Autism Dev Disord       Date:  2000-10

Review 2.  Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy.

Authors:  R Kneen; R E Appleton
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

3.  Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet.

Authors:  K J Seymour; S Bluml; J Sutherling; W Sutherling; B D Ross
Journal:  MAGMA       Date:  1999-03       Impact factor: 2.310

Review 4.  Corticosteroids in the management of the paediatric epilepsies.

Authors:  R Gupta; R Appleton
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

5.  Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.

Authors:  Madeline E Rhodes; Jayanth Talluri; Jacob P Harney; Cheryl A Frye
Journal:  Epilepsy Behav       Date:  2005-09       Impact factor: 2.937

6.  Magnetoencephalography in children with Landau-Kleffner syndrome and acquired epileptic aphasia.

Authors:  D F Sobel; M Aung; H Otsubo; M C Smith
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

7.  Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy.

Authors:  Seung-Koo Lee; Jinna Kim; Heung Dong Kim; Joon Soo Lee; Young Mock Lee
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 8.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

Review 9.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  Recurrent seizures following focal motor status epilepticus in a patient with non-ketotic hyperglycemia and acute cerebral infarction.

Authors:  Jung-Ju Lee; Jinwoong Jung; Kyusik Kang; Jong-Moo Park; Hyeeun Shin; Ohyun Kwon; Byung-Kun Kim
Journal:  J Epilepsy Res       Date:  2014-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.